Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: ATRA) | Delayed: 8.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.35 | 52 Week High | $40.80 | |||
| Open | $8.35 | 52 Week Low | $12.45 | |||
| Day High | $8.35 | P/E | N/A | |||
| Day Low | $8.35 | EPS | $0.00 | |||
| Volume | 20 | |||||
